Gilead’s Lenacapavir Access Strategy in R...

By João L. Carapinha

October 14, 2024

Gilead Sciences, Inc. has announced important initiatives to increase access to lenacapavir, a potentially transformative HIV medication
Iraq Roche Partnership to Enhance Healthcare Services
FDA’s Opdivo Lung Cancer Approval
The VA’s Journey with Early Adoption of AI in Healthcare
Internet Use and Adolescent Mental Health: The Role of Parental Support
Boosting HPV Cervical Cancer Awareness: Key Insights on Public Survey
Enhancing Global Health through Regulatory Collaboration
Enhancing Child Mental Health Services with Digital Interventions
The Trump Drug Policy Change: A Reverse Course
Created and Validated by FDA: AI Drug Safety Surveillance Tool
The Role of School-Based Health Centres in Advancing Health Equity
Enhancing Care in Abu Dhabi: The New ABA Guidelines for Autism
Eli Lilly’s Alzheimer’s Drug Kisunla Gains Approval in Japan